- INTRODUCTION
- 1. A Short History of Vaccination
Susan L. Plotkin and Stanley A. Plotkin
- 2. The History of Polio Vaccine Development
Frederick C. Robbins
- 3. The Immunology of Vaccination
Gordon Ada
- 4. Overview of Vaccine Manufacturing and Quality Assurance
Gary B. Ebbert, Eugene D. Mascolo and Howard R. Six
- 5. General Immunization Practices
John C. Watson and Georges Peter
- 6. Smallpox and Vaccinia
Donald A. Henderson and Bernard Moss.
- 7. Immunization in the Immunocompromised Host
Per Ljungman
- LICENSED VACCINES
- 8. Bacille Calmette-Guérin Vaccine
Kim Connelly Smith and Jeffrey R. Starke
- 9. Diphtheria Toxoid
Edward A. Mortimer Jr. and Melinda Wharton
- 10. Hepatitis B Vaccine
Francis J. Mahoney and Mark Kane
- 11. Haemophilus influenzae Vaccines
Joel I. Ward and Kenneth M. Zangwill
- 12. Measles Vaccine
Stephen C. Redd, Lauri E. Markowitz and Samuel L. Katz
- 13. Mumps Vaccine
Stanley A. Plotkin and Melinda Wharton
- 14. Pertussis Vaccine
Kathryn M. Edwards, Michael D. Decker and Edward A. Mortimer Jr.
- 15. Inactivated Polio Vaccine
Stanley A. Plotkin, Andrew D. Murdin and Emmanuel Vidor
- 16. Live Attenuated Poliovirus Vaccines
Roland W. Sutter, Stephen L. Cochi and Joseph L. Melnick
- 17. Rubella Vaccine
Stanley A. Plotkin
- 18. Tetanus Toxoid
Steven G. F. Wassilak , Walter A. Orenstein and Roland W. Sutter
- 19. Varicella Vaccine
Anne A. Gershon, Michiaki Takahashi and C. Jo White
- 20. Combination Vaccines
Michael D. Decker and Kathryn M. Edwards
- VACCINES RECOMMENDED FOR ADULTS
- 21. Inactivated Influenza Vaccines
Edwin D. Kilbourne and Nancy H. Arden
- 22. Pneumococcal Vaccine
David S. Fedson, Daniel M. Musher and Juhani Eskola
- VACCINES FOR SPECIAL RISK GROUPS AND SELECTED GEOGRAPHICAL AREAS
- 23. Adenovirus Vaccines
Charlotte A. Gaydos and Joel C. Gaydos
- 24. Anthrax
Philip S. Brachman and Arthur M. Friedlander
- 25. Cholera Vaccines
David A. Sack and Michel Cadoz
- 26. Hepatitis A Vaccine
Stephen M. Feinstone and Ian D. Gust
- 27. Japanese Encephalitis Vaccines
Theodore F. Tsai, Gwong-Jen J. Chang and Yong Xin Yu
- 28. Meningococcal Vaccines
Martha L. Lepow, Bradley A. Perkins, Patricia A. Hughes and Jan T. Poolman
- 29. Miscellaneous Limited-Use Vaccines
George R. French and Stanley A. Plotkin
- 30. Plague
Richard W. Titball, Stephen Eley, Diane E. Williamson and David T. Dennis
- 31. Rabies Vaccine
Stanley A. Plotkin, Charles E. Rupprecht and Hilary Koprowski
- 32. Tick-Borne Encephalitis Vaccine
Noel P. Barrett, Friedrich Dorner and Stanley A. Plotkin
- 33. Typhoid Fever Vaccines
Myron M. Levine
- 34. Yellow Fever
Thomas P. Monath
- SELECTED VACCINES OF THE FUTURE
- 35. New Technologies for Making Vaccines
Ronald W. Ellis
- 36. Cytomegalovirus Vaccines
Stanley A. Plotkin
- 37. Live Influenza Virus Vaccine
Hunein F. Maassab, Louise M. Herlocher and Martin L. Bryant
- 38. Human Immunodeficiency Virus
Marc P. Girard and Jean-Louis Excler
- 39. Lyme Disease Vaccine
Janine Evans and Erol Fikrig
- 40. Parasitic Disease Vaccines
Peter J. Hotez
- 41. Rotavirus Vaccines
Fred H. Clark, Roger I. Glass and Paul A. Offit
- PUBLIC HEALTH AND REGULATORY ISSUES
- 42. Public Health Considerations - United States
Walter A. Orenstein, Alan R. Hinman and Lance E. Rodewald
- 43. Immunization in Europe
David M. Salisbury and Sieghart Dittmann
- 44. Vaccination Programs in Developing Countries
Felicity T. Cutts and Jean-Marc Olivé
- 45. Cost-Benefit and Cost-Effectiveness Analysis of Vaccine Policy
Mark A. Miller and Alan R. Hinman
- 46. Vaccines for International Travel
Elizabeth Day Barnett, Robert T. Chen and Michel Rey
- 47. Vaccines for Healthcare Workers
David J. Weber, Kristen Weigle and William A. Rutala
- 48. Regulation and Testing of Vaccines
Paul D. Parkman and Carolyn M. Hardegree
- 49. Safety of Vaccines
Robert T. Chen
- 50. U.S. Law
Edmund W. Kitch, Geoffrey Evans and Robyn Gopin
- EPILOGUE
- Appendix 1. Recommendations of the Advisory Committee on Immunization Practices
- Appendix 2. Immunobiologicals and Their Manufacturers and Distributors
- Appendix 3. Representative Vaccine Information Statement (VIS)
- Appendix 4. Case Definitions for Selected VaccinePreventable Diseases Under Public Health Surveillance in the United States
|
|